Differentiation and reversal of malignant changes in colon cancer through PPARgamma (Q77291051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Differentiation and reversal of malignant changes in colon cancer through PPARgamma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

Sarraf P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Mueller E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Jones D

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

King FJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

DeAngelo DJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Partridge JB

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Holden SA

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Chen LB

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Fletcher C

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Spiegelman BM

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

1046-1052

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/2030

4 December 2019

exact match

0 references

cites work

The nuclear receptor superfamily: the second decade

1 reference

7 January 2021

Adipogenesis and obesity: rounding out the big picture

1 reference

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

7 January 2021

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

7 January 2021

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

1 reference

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

7 January 2021

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

1 reference

7 January 2021

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

1 reference

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

7 January 2021

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

1 reference

7 January 2021

Clinical highlights from the National Cancer Data Base: 1997.

1 reference

7 January 2021

Gene expression profiles in normal and cancer cells

1 reference

7 January 2021

Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models

1 reference

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

7 January 2021

Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice

1 reference

7 January 2021

A synthetic inhibitor of the mitogen-activated protein kinase cascade

1 reference

7 January 2021

Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain

1 reference

7 January 2021

Studies of intestinal stem cells using normal, chimeric, and transgenic mice

1 reference

7 January 2021

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

1 reference

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma.

1 reference

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

7 January 2021

Identifiers

DOI

10.1038/2030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9734398%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference